Bausch + Lomb Corporation (BLCO) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$16.00
Price Target
$19.00
Target Range
$16.00 — $21.00
Analyst Rating
Hold
Forward P/E20.2x
Trailing P/E-15.7x
Forward PEG—
Implied Growth+228.3%
Median Target$20.00
Analyst Spread26.3%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$16
+0.0%
Consensus
$19
+18.8%
Bull Case
$21
+31.3%
BLCO Price Target Analysis
Updated May 6, 2026As of May 6, 2026, Bausch + Lomb Corporation (BLCO) has a Wall Street consensus price target of $19.00, based on estimates from 16 covering analysts. With the stock currently trading at $16.00, this represents a potential upside of +18.8%. The company has a market capitalization of $5.70B.
Analyst price targets range from a low of $16.00 to a high of $21.00, representing a 26% spread in expectations. The median target of $20.00 differs from the mean, suggesting potential outlier estimates.
The current analyst consensus rating is Hold, with 7 analysts rating the stock as a Buy or Strong Buy,8 rating it Hold, and 1 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, BLCO trades at a trailing P/E of -15.7x and forward P/E of 20.2x. Analysts expect EPS to grow +228.3% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+28.0%
Avg Forward P/E49.2x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 HSICHenry Schein, Inc. | $8.3B | $72.44 | $86.43 | +19.3% | Hold | 13.6x | 32 |
 ATRCAtriCure, Inc. | $1.4B | $28.01 | $50.67 | +80.9% | Buy | 373.5x | 19 |
 LNTHLantheus Holdings, Inc. | $5.6B | $86.15 | $101.00 | +17.2% | Buy | 16.6x | 17 |
 JNJJohnson & Johnson | $541.3B | $224.62 | $249.27 | +11.0% | Buy | 19.4x | 40 |
 ABTAbbott Laboratories | $150.0B | $86.25 | $128.71 | +49.2% | Buy | 15.7x | 41 |
 COOThe Cooper Companies, Inc. | $12.0B | $61.12 | $93.86 | +53.6% | Buy | 13.2x | 24 |
 HOLXHologic, Inc. | $17.0B | $76.01 | $79.00 | +3.9% | Hold | 17.2x | 42 |
 IARTIntegra LifeSciences Holdings Corporation | $1.1B | $14.00 | $12.00 | -14.3% | Buy | 6.0x | 26 |
 ALGNAlign Technology, Inc. | $12.5B | $173.94 | $203.60 | +17.1% | Buy | 15.3x | 33 |
 BHCBausch Health Companies Inc. | $2.1B | $5.65 | $8.00 | +41.6% | Buy | 1.3x | 38 |
Upside Potential Comparison
ATRCCOOABTBHCHSICLNTHALGNJNJSee BLCO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BLCO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BLCO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBLCO — Frequently Asked Questions
Quick answers to the most common questions about buying BLCO stock.
What is the BLCO stock price target for 2026?
Bausch + Lomb Corporation (BLCO) has a consensus 12-month price target of $19, implying 18.8% upside from $16. The 16 analysts covering BLCO see moderate appreciation potential.
Is BLCO a buy, sell, or hold?
BLCO has a consensus rating of "Hold" based on 16 Wall Street analysts. The rating breakdown is mixed, with 8 Hold ratings making up the largest segment. The consensus 12-month price target of $19 implies 18.8% upside from current levels.
Is BLCO stock overvalued or undervalued?
BLCO trades at a forward P/E of 20.225x, representing a moderate valuation. With analysts targeting $19 (18.8% implied move), the stock appears reasonably valued with upside.
How high can BLCO stock go?
The most bullish Wall Street analyst has a price target of $21 for BLCO, while the most conservative target is $16. The consensus of $19 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover BLCO stock?
BLCO is well covered by analysts, with 16 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 7 have Buy ratings, 8 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the BLCO stock forecast?
The 12-month BLCO stock forecast based on 16 Wall Street analysts shows a consensus price target of $19, with estimates ranging from $16 (bear case) to $21 (bull case). The median consensus rating is "Hold".
What is BLCO's forward P/E ratio?
BLCO trades at a forward P/E ratio of 20.2x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy BLCO stock?
Wall Street analysts are optimistic on BLCO, with a "Hold" consensus rating and $19 price target (18.8% upside). 7 of 16 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do BLCO price targets vary so much?
BLCO analyst price targets range from $16 to $21, a 26% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $19 consensus represents the middle ground.